Tag: Sapien 3 Ultra
Clinical outcomes similar at one-year for leading TAVI platforms in real-world registry, but stroke rates differ
A comparison of two latest-generation self-expanding and balloon-expandable transcatheter aortic...
FDA approves Sapien 3 Ultra, Sapien 3, and CoreValve for low-risk TAVI
On 16 August, the US Food and Drug Administration (FDA) approved Edwards Lifesciences’ Sapien 3 ...
Edwards Lifesciences drops Centera in favour of focusing on Sapien range
Edwards Lifesciences—in a press statement announcing its global second quarter (Q2) financial re...
Edwards Lifesciences to discontinue its self-expanding valve Centera
Edwards Lifesciences has announced it has made the “difficult decision” to discontinue its self-...
Edwards Lifesciences issues urgent safety notice for Sapien 3 Ultra
Edwards Lifesciences has issued an urgent safety notice for the latest generation of its Sapien ...
